** Shares of NeuBase Therapeutics rise ~22.2% to 87 cents premarket
** Co said late on Friday it has decided to dissolve, liquidate and distribute to stockholders its available assets
** The board expects to approve a formal plan of dissolution in the near future - NBSE
** Co said it has been evaluating strategic alternatives that include an acquisition, merger, business combination, dissolution or other transaction
** Up to last close, stock was down 85.5% in the last 12 months
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments